← Back to news

Markets

AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®

Y

Is ZoomInfo Technologies Inc. (GTM) One of the Best Tech Stocks Under $5 to Buy?

Y

Is Grab Holdings Limited (GRAB) One of the Best Tech Stocks Under $5 to Buy?

Y

Toyota Motor Corporation’s (TM) Global Vehicle Sales Dropped for a Third Consecutive ‌Month in April, Reuters Reports

Y

Barclays Lifts PT on Royal Bank of Canada (RY) Following Q1 Results

Y

Barclays Lifts PT on The Toronto-Dominion Bank (TD) Following Q2

Y

T-Mobile US (TMUS) Announces Multi-Year Partnership With the United States Golf Association (USGA)

Y

Job openings in April surged to 7.6 million, the highest in nearly two years

E

DA Davidson Cuts PT on Salesforce, Inc. (CRM) Following Q1 Results

Y

Is Chevron Corporation (CVX) One of the Top Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing?

Y

Is Sandisk Corporation (SNDK) One of the Top Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing?

Y

Here’s Why Long Cast Advisors is Holding Mama’s Creations (MAMA)

Y

Is Micron Technology (MU) One of the Top Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing?

Y

Here’s What Analysts Are Saying About Royal Bank of Canada (RY) Post Q1

Y

High Earners Are Skipping Treasuries for These 3 Tax Free Muni ETFs Yielding Over 4 Percent After Tax

Y

Jefferies Lifts PT on The Toronto-Dominion Bank (TD) But Maintains a Hold Rating

Y

Mizuho Lifts PT on Arm Holdings plc (ARM) After Analysis of the Memory Market and Impact of Agentic AI

Y

Jefferies Remains Bullish on Palo Alto Networks (PANW)

Y

Bra Sales Power Victoria’s Secret Turnaround and Shares Soar

Y

Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans

Y

Is Meta Platforms (META) One of the Best Stocks to Buy Now for Long Term Growth?

Y

Why Alphabet Inc. (GOOG) is One of the Best Stocks to Buy Now for Long Term Growth

Y

Why Wall Street Thinks You Should Buy Broadcom Stock Before June 3

Y

Long Cast Advisors’ Views in Research Solutions’ (RSSS) Insights on Business Resilience and Innovation

Y

ICAS members call for income tax and NI reform after Scottish election

Y

Varon Corp's Bucked Up lands C$500,000 order as Ozop deal nears close

Y

Where Will Poet Technologies Stock Be in 5 Years?

Y

Galaxy Launches OTC Prediction Markets

Y

Dollar Slips on US-Iran Peace Hopes

Y

Are Jobs Back? Openings Surged To Two-Year High In April

Y

iShares Clean Energy or Invesco Solar: Which Energy ETF Is a Better Bet?

Y

GlobalX Airlines accuses shareholder of undermining cargo business

Y

Should You Buy the SpaceX IPO? Here's My Honest Take

Y

Sheikh Ahmed Dalmook Al Maktoum’s Inmā Emirates Holdings Launches Grant Program To Help Scale Climate Resilience Ventures

Y

The stock market had a great May. Here's what actually drove it

Y

Oil market could be underpricing risks, Vitol's Bahrain chief says

Y

MicroStrategy Sells Bitcoin for First Time Since 2022: Should You Panic?

Y

Teens are up against the worst summer job market in nearly 80 years—they’re fighting against hundreds to work at ice cream shops and swimming pools

Y

Oil Prices Tumbled Nearly 20% in May (The Biggest Drop Since 2020). Is it Time to Sell Your Oil Stocks?

Y

Why Pipeline Income Investors Are Betting on Energy Transfer and Enterprise Products

Y

Shake Shack cuts Q2 2026 and full-year guidance on macro uncertainty

Y

Bitcoin Crashes Below $70K After Michael Saylor's Strategy Finally Sells BTC

Y

Parex Resources completes $500m acquisition of Frontera E&P assets

Y

1 Legally Protected Monopoly Yielding Over 4% That Is Structurally Primed to Make Patient Investors Richer

Y

3 Reasons Cathie Wood's Buying Nvidia Stock This Week

Y

Amcor secures cleanroom certification for Carolina thermoforming site

Y

A $5 Billion Reason to Buy Salesforce Stock Now

Y

Nvidia CEO Jensen Huang Is Building the Future Faster Than Infrastructure Can Support It

Y

Is NVIDIA Corporation (NVDA) One of the Best Stocks to Buy Now for Long Term Growth?

Y

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Y